Literature DB >> 12792686

[Occurrence of diabetes mellitus in women with prior gestational hyperglycemia].

Márcia Rocha Gabaldi Silva1, Iracema de Mattos Paranhos Calderon, Luciana Colnago Gonçalves, Flávio Ferrari Aragon, Carlos Roberto Padovani, Walkyria de Paula Pimenta.   

Abstract

OBJECTIVE: To estimate the prevalence of glucose intolerance (diabetes mellitus and impaired glucose tolerance) in women who had their glucose tolerance evaluated and followed up during pregnancy.
METHODS: Over the last 12 years since the index pregnancy, from a total of 3,113 pregnant women seen in an obstetrics clinic, 551 were randomly selected and proportionally to the number of women in each group. Of these, 529 could be evaluated and had been classified as follows: 250 in group IA (normal glucose tolerance); 120 in group IB (daily hyperglycemia); 72 in group IIA (abnormal oral glucose tolerance test); and 87 in group IIB (abnormal oral glucose tolerance test and daily hyperglycemia). The evaluation consisted of measuring fasting plasma glucose and when the results ranged between 6.1 and 6.9 mmol/L, patients were submitted to oral glucose tolerance test.
RESULTS: Prevalence of diabetes mellitus was: IA, 1.6%; IB, 16.7%; IIA, 23.6%; and IIB, 44.8% (IA < [IB = IIA] < IIB; p<0.05). This difference between the groups remained the same for the eight years. Women in IA group were different from others regarding age, parity, and diabetes family history.
CONCLUSION: Hyperglycemia (high plasma glucose levels) and abnormal oral glucose tolerance test during pregnancy are equally effective in predicting the risk for developing maternal diabetes. When both tests are abnormal, this risk is much higher.

Entities:  

Mesh:

Year:  2003        PMID: 12792686     DOI: 10.1590/s0034-89102003000300013

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  3 in total

1.  Oxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women.

Authors:  Rafael Bottaro Gelaleti; Débora Cristina Damasceno; Paula Helena Ortiz Lima; Daisy Maria Favero Salvadori; Iracema de Mattos Paranhos Calderon; José Carlos Peraçoli; Marilza Vieira Cunha Rudge
Journal:  Diabetol Metab Syndr       Date:  2015-01-15       Impact factor: 3.320

2.  IRS-1 gene polymorphism and DNA damage in pregnant women with diabetes or mild gestational hyperglycemia.

Authors:  Rafael B Gelaleti; Débora C Damasceno; Daisy M F Salvadori; João Paulo C Marcondes; Paula H O Lima; Glilciane Morceli; Iracema M P Calderon; Marilza V C Rudge
Journal:  Diabetol Metab Syndr       Date:  2015-04-02       Impact factor: 3.320

3.  Diagnostic protocol for gestational diabetes mellitus (GDM) (IADPSG/ADA, 2011): influence on the occurrence of GDM and mild gestational hyperglycemia (MGH) and on the perinatal outcomes.

Authors:  Mariana Pinto Sirimarco; Helena Maciel Guerra; Eduardo Guimarães Lisboa; Joice Monalisa Vernini; Bianca Nicolosi Cassetari; Roberto Antonio de Araujo Costa; Marilza Vieira Cunha Rudge; Iracema de Mattos Paranhos Calderon
Journal:  Diabetol Metab Syndr       Date:  2017-01-03       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.